Cumberland Pharmaceu (CPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 8,320 | 8,073 | 9,056 | 10,537 | 10,262 |
| Cost of Goods | 3,325 | 1,328 | 1,741 | 2,417 | 2,266 |
| Gross Profit | 4,995 | 6,745 | 7,315 | 8,120 | 7,996 |
| Operating Expenses | 9,674 | 8,636 | 9,491 | 8,862 | 10,008 |
| Operating Income | -4,354 | -1,563 | -1,436 | -324 | -1,746 |
| Interest Expense | 28 | 20 | 26 | 24 | 36 |
| Other Income | 7 | 7 | 2,194 | 5 | 5 |
| Pre-tax Income | -4,375 | -1,576 | 732 | -343 | -1,777 |
| Income Tax | 27 | -8 | 8 | 8 | 18 |
| Net Income Continuous | -4,388 | -1,584 | 725 | -351 | -1,788 |
| Net Income Discontinuous | 503 | 497 | 499 | 495 | 872 |
| Minority Interests | -37 | -31 | -5 | -22 | -32 |
| Net Income | $-3,848 | $-1,055 | $1,229 | $167 | $-884 |
| EPS Basic Total Ops | -0.26 | -0.07 | 0.08 | 0.01 | -0.06 |
| EPS Basic Continuous Ops | -0.30 | -0.10 | 0.05 | -0.02 | -0.12 |
| EPS Basic Discontinuous Ops | 0.04 | 0.03 | 0.03 | 0.03 | 0.06 |
| EPS Diluted Total Ops | -0.26 | -0.07 | 0.08 | 0.01 | -0.06 |
| EPS Diluted Continuous Ops | -0.30 | -0.10 | 0.05 | -0.02 | -0.12 |
| EPS Diluted Discontinuous Ops | 0.04 | 0.03 | 0.03 | 0.03 | 0.06 |
| EBITDA(a) | $-3,277 | $-490 | $-208 | $903 | $-522 |